Mutz Christopher sold ANIP
March 6, 2026 · Form 4 insider transaction
Mutz Christopher sold 2,121 shares of ANI Pharmaceuticals, Inc. at $74.22 per share, a transaction worth $157.4K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,121
Price
$74.22
Total value
$157.4K
InsiderMutz Christopher
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 6, 2026
Filing dateMarch 10, 2026
Shares owned after101,387
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.; The shares were sold in multiple trades at prices ranging from $73.14 to $75.00. The price reported above reflects the weighted average sales price.